Navigation Menu+
No Smoke without Fire – Prescription Drugs tied to Birth Defects
Read more

Drug company GlaxoSmithKline paid $1 billion in fines to the Department of Justice (DoJ) to settle charge of fraudulent marketing of some of its most popular products, including anti-emetic agent Zofran (ondansetron). It has also agreed to put up a $2 billion fund to settle civil lawsuits. Other drugs included in the charges are Paxil (paroxetine, an antidepressant), Wellbutrin (bupropion, also an antidepressant), and...

Read more